The effect of COVID vaccination timing on the seroprevalence of IgG antibodies: evidence from the Guayas region of Ecuador.

Malacatus-Arboleda A, Barbotó-Ramírez E, Sánchez GE, Moscoso B, Rhodes LA, Coloma J, Guevara Á, Espinoza-Fuentes F, Fernández-Cadena JC, Morey-León G, Andrade-Molina D

Open source

DOI
10.3389/fpubh.2025.1537049
Published
2025
Container
Frontiers in public health
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fpubh.2025.1537049,
  title = {The effect of COVID vaccination timing on the seroprevalence of IgG antibodies: evidence from the Guayas region of Ecuador.},
  author = {Malacatus-Arboleda A and Barbotó-Ramírez E and Sánchez GE and Moscoso B and Rhodes LA and Coloma J and Guevara Á and Espinoza-Fuentes F and Fernández-Cadena JC and Morey-León G and Andrade-Molina D},
  year = {2025},
  journal = {Frontiers in public health},
  doi = {10.3389/fpubh.2025.1537049},
  url = {https://doi.org/10.3389/fpubh.2025.1537049}
}

RIS

TY  - JOUR
TI  - The effect of COVID vaccination timing on the seroprevalence of IgG antibodies: evidence from the Guayas region of Ecuador.
AU  - Malacatus-Arboleda A
AU  - Barbotó-Ramírez E
AU  - Sánchez GE
AU  - Moscoso B
AU  - Rhodes LA
AU  - Coloma J
AU  - Guevara Á
AU  - Espinoza-Fuentes F
AU  - Fernández-Cadena JC
AU  - Morey-León G
AU  - Andrade-Molina D
PY  - 2025
JO  - Frontiers in public health
DO  - 10.3389/fpubh.2025.1537049
UR  - https://doi.org/10.3389/fpubh.2025.1537049
ER  - 

APA

A, M., E, B., GE, S., B, M., LA, R., J, C., Á, G., F, E., JC, F., G, M., & D, A. (2025). The effect of COVID vaccination timing on the seroprevalence of IgG antibodies: evidence from the Guayas region of Ecuador.. Frontiers in public health. https://doi.org/10.3389/fpubh.2025.1537049

Source records